You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

POTASSIUM CHLORIDE 40MEQ Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Potassium Chloride 40meq patents expire, and when can generic versions of Potassium Chloride 40meq launch?

Potassium Chloride 40meq is a drug marketed by Fresenius Kabi Usa, Nexus, Baxter Hlthcare, and Icu Medical Inc. and is included in sixteen NDAs.

The generic ingredient in POTASSIUM CHLORIDE 40MEQ is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for POTASSIUM CHLORIDE 40MEQ?
  • What are the global sales for POTASSIUM CHLORIDE 40MEQ?
  • What is Average Wholesale Price for POTASSIUM CHLORIDE 40MEQ?
Summary for POTASSIUM CHLORIDE 40MEQ
Drug patent expirations by year for POTASSIUM CHLORIDE 40MEQ
Pharmacology for POTASSIUM CHLORIDE 40MEQ

US Patents and Regulatory Information for POTASSIUM CHLORIDE 40MEQ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa POTASSIUM CHLORIDE 40MEQ potassium chloride INJECTABLE;INJECTION 211087-004 Sep 9, 2020 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Fresenius Kabi Usa POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 213523-004 Mar 9, 2021 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Icu Medical Inc POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 019685-004 Oct 17, 1988 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Icu Medical Inc POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 019691-009 Mar 24, 1988 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

POTASSIUM CHLORIDE 40MEQ Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Pharma Grade Potassium Chloride

Introduction to Pharma Grade Potassium Chloride

Pharma grade potassium chloride is a critical component in various medical and industrial applications. It is widely used in the treatment of potassium deficiency states, particularly when oral replacement is not feasible. Here, we delve into the market dynamics, growth drivers, and financial trajectory of this essential medication.

Market Size and Growth Projections

The global pharma grade potassium chloride market is anticipated to experience significant growth over the coming years. As of 2024, the market size is estimated to be around $15 million, and it is forecasted to reach $22 million by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during this period[1].

Key Applications

Pharma grade potassium chloride is utilized in several key applications:

Injectable Solutions

This is one of the leading segments, accounting for a significant market share. Potassium chloride injections are used to maintain serum potassium levels and for potassium supplementation, especially in fluid-restricted patients[2].

Hemodialysis Solutions

Potassium chloride is essential in hemodialysis solutions to manage electrolyte balance during the dialysis process.

Pharmaceuticals

It is used in various pharmaceutical formulations to treat hypokalemia and other potassium deficiency states.

Other Applications

Other applications include its use in the food industry, oil & gas sector, and as a fertilizer in agriculture, although these are not exclusively pharma grade[3][4].

Types of Pharma Grade Potassium Chloride

The market is segmented by type into:

Particle

This form is widely used in pharmaceutical and medical applications.

Powder

The powder form is also significant, particularly in the production of injectable solutions and other pharmaceutical products[1].

Regional Outlook

The global market is geographically segmented, with Europe being the largest production area, accounting for about 30% of the market share. China and the rest of Asia also hold substantial shares, collectively exceeding 50% of the global market[1].

Key Players

The market is dominated by several key players, including:

ICL (ICL-IP)

K+S

Morton

These companies play a crucial role in the production and distribution of pharma grade potassium chloride[1].

Growth Drivers

Several factors are driving the growth of the pharma grade potassium chloride market:

Increasing Demand in Healthcare

The need for effective treatments for hypokalemia and other potassium deficiency states is a major driver. Potassium chloride is a critical medication in these scenarios[2][3].

Agricultural Sector

Although not exclusively pharma grade, the increasing adoption of potassium chloride in fertilizers to enhance crop yield and quality also supports the overall demand for potassium chloride[3][4].

Industrial Applications

The use of potassium chloride in the production of potassium-based chemicals and in the oil & gas industry further boosts demand[4].

Market Constraints and Challenges

Despite the growth drivers, there are several challenges facing the market:

Fluctuating Raw Material Prices

The price of raw materials, such as potassium, can fluctuate significantly due to various factors, including geopolitical events and demand from other industries[3].

Health Issues

The use of chemical fertilizers, including potassium chloride, can lead to health issues, which may hinder market growth[3].

Economic Impact of COVID-19

The COVID-19 pandemic has had a significant impact on the global economy, affecting the production and distribution of pharma grade potassium chloride. However, the market is expected to readjust and grow in the post-pandemic period[1].

Financial Trajectory

The financial trajectory of the pharma grade potassium chloride market is promising:

  • Current Market Size: Estimated at $15 million in 2024.
  • Projected Market Size: Forecasted to reach $22 million by 2032.
  • CAGR: Expected to grow at a CAGR of 6.5% from 2024 to 2032[1].

Market Trends

Several trends are shaping the market:

Increasing Adoption in Fertilizers

The use of potassium chloride in fertilizers is a significant trend, driven by the need for higher agricultural output to meet global food demand[3][4].

Industrial Sector Growth

The demand from the industrial sector, particularly for producing potassium-based chemicals, is another key trend[4].

Regulatory Considerations

Regulatory changes and sanctions, such as those imposed by the European Union on feedstock potash, can impact market dynamics and prices[3].

Clinical Use and Safety Considerations

Pharma grade potassium chloride, especially in injectable forms, requires careful administration:

  • Continuous Cardiac Monitoring: Necessary to monitor serum potassium levels and acid-base balance[2].
  • Risk of Solute Overload: High concentrations can lead to solute overload, causing congested states with peripheral and pulmonary edema[5].

Conclusion

The pharma grade potassium chloride market is poised for significant growth, driven by increasing demand in healthcare, agricultural, and industrial sectors. However, it faces challenges such as fluctuating raw material prices and health issues associated with chemical fertilizers.

Key Takeaways

  • The global pharma grade potassium chloride market is expected to grow from $15 million in 2024 to $22 million by 2032.
  • Key applications include injectable solutions, hemodialysis solutions, and pharmaceuticals.
  • Europe is the largest production area, followed by China and the rest of Asia.
  • Major drivers include increasing demand in healthcare and agricultural sectors.
  • Challenges include fluctuating raw material prices and health issues.

FAQs

  1. What is the primary use of pharma grade potassium chloride?

    • The primary use is in the treatment of potassium deficiency states, particularly when oral replacement is not feasible.
  2. Which region is the largest producer of pharma grade potassium chloride?

    • Europe is the largest production area, accounting for about 30% of the global market share.
  3. What are the key types of pharma grade potassium chloride?

    • The market is segmented into particle and powder forms.
  4. How is the COVID-19 pandemic affecting the market?

    • The pandemic has had a significant impact, but the market is expected to readjust and grow in the post-pandemic period.
  5. What are the major growth drivers for the pharma grade potassium chloride market?

    • Increasing demand in healthcare, agricultural sector, and industrial applications are major drivers.

Sources

  1. News Channel Nebraska: "Pharma Grade Potassium Chloride Market Dynamics till 2032 | Growth Drivers, Market Constraints and Challenges"[1]
  2. DailyMed: "POTASSIUM CHLORIDE injection, solution"[2]
  3. Cognitive Market Research: "Potassium Chloride market size was $12.56 Billion in 2021!"[3]
  4. Verified Market Research: "Potassium Chloride Market Size, Share, Trends & Forecast"[4]
  5. DailyMed: "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP"[5]

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.